# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BMO Capital analyst John McNulty maintains Linde (NASDAQ:LIN) with a Outperform and maintains $477 price target.
Linde to supply clean hydrogen to Dow Inc.'s Fort Saskatchewan Path2Zero Project in Canada, investing $2B for world's l...
Linde (NASDAQ: LIN) announced today it has signed a long-term agreement for the supply of clean hydrogen to Dow's Fort Sask...